In this context, the TGF-β signaling pathway has been shown to play a significant role in the development of CCM, as it may potentiate the parasitic burden by downregulating the intracellular immune response against T. cruzi (Ferreira et al., 2016; da et al., 2019). Here, TGFB1 is linked to cerebral cavernous malformation.